局部晚期直肠癌新辅助放化疗疗效与血管内皮生长因子水平的关系

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1197 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨局部进展期直肠癌新辅助放化疗敏感性与血清血管内皮生长因子（sVEGF）水平的关系。方法：应用酶联免疫吸附法（ELISA）检测58例局部进展期直肠癌患者治疗前、后sVEGF水平，并分析其与新辅助放化疗疗效的关系。结果：治疗后患者sVEGF水平均有显著降低（P＜0.01），不同病理分级患者sVEGF表达水平差异有统计学意义（P＜0.05）。结论：sVEGF水平的变化可作为局部进展期直肠癌新辅助放化疗的疗效评价的参考。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	朱胜裕
	沈乐荣
	叶香华

关键词 ：直肠肿瘤, 新辅助放化疗, 血管内皮生长因子

Abstract：Objective: To investigate the relationship between levels of serum vascular endothelial growth factors (sVEGF) and effectiveness of neoadjuvant chemoradiotherapy on locally advanced rectal cancer. Methods: Levels of sVEGF were measured by enzyme-linked immunosorbent assay (ELISA) before and after treatment in 58 patients with locally advanced rectal cancer. The relationship between levels of sVEGFs and response of neoadjuvant chemoradiotherapy was analysed. Results: Levels of sVEGF were significantly decreased after treatment (P<0.01). Levels of sVEGF were different among patients with different pathological grades (P<0.05). Conclusion: The change of sVEGF level is able to evaluate the effectiveness of neoadjuvant chemoradiotherapy on locally advanced rectal cancer.

Key words： rectal neoplasms neoadjuvant chemoradiotherapy vascular endothelial growth factor

PACS:

作者简介: 朱胜裕（1980-），男，浙江绍兴人，主治医师

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2018/V48/I1/63

[1] Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013[J]. JAMA Oncol, 2015, 1(4): 505-527.

[2] GRETO D, PAIAR F, SAIEVA C, et al. Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience[J]. Radiol Med, 2013, 118(4): 570-582.

[3] 陈中皓, 王学志, 徐铭, 等. Survivin、MMP-2、nm23-H1、VEGF及其受体Flt-1在结直肠癌中的表达及临床意义[J].中国癌症杂志, 2011, 21(4): 290-293.

[4] GARLAND M L, VATHER R, BUNKLEY N, et al. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer[J]. Int J Colorectal Dis, 2014, 29(3): 301-307.

[5] 段泽星, 谢立群. VEGF在肿瘤生长和血管生成中的作用[J]. 世界华人消化杂志, 2010, 18(27): 2894-2900.

[6] 李京佳, 林相国, 许涛, 等. VEGF家族及其在肿瘤生长中作用的研究[J]. 现代生物医学进展, 2012, 12(4): 777-779, 701.

[7] 邹文萍, 唐国强, 李光明. VEGF及其受体的生物学特性[J]. 四川生理科学杂志, 2012, 34(3): 123-126.

[8] HANLY A M, RYAN E M, ROGERS A C, et al. Multicenter evaluation of rectal cancer reimaging post neoadjuvant (merrion) therapy[J]. Ann Surg, 2014, 259(4): 723-727.

[9] BATTERSBY N J, MORAN B, YU S, et al. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy[J]. Expert Rev Gastroenterol Hepatol, 2014, 8(6): 703-719.

[10] CAI P Q, WU Y P, XIN A, et al. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Eur diol, 2014 , 24(11): 2962-2970.

[11] 何金华, 裴波, 潘定国, 等. 局部进展期直肠癌新辅助放化疗后缓解率的准确性评估[J]. 现代肿瘤医学, 2016, 24(3): 495-498.